Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.

Alegre-Sancho JJ, Juanola X, Rodríguez-Heredia JM, Manero J, Villa-Blanco I, Laiz A, Arteaga MJ, Cea-Calvo L, González CM

Open source

DOI
10.1097/md.0000000000025223
Published
2021 Apr 2
Container
Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000025223,
  title = {Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.},
  author = {Alegre-Sancho JJ and Juanola X and Rodríguez-Heredia JM and Manero J and Villa-Blanco I and Laiz A and Arteaga MJ and Cea-Calvo L and González CM},
  year = {2021},
  journal = {Medicine},
  doi = {10.1097/md.0000000000025223},
  url = {https://doi.org/10.1097/md.0000000000025223}
}

RIS

TY  - JOUR
TI  - Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.
AU  - Alegre-Sancho JJ
AU  - Juanola X
AU  - Rodríguez-Heredia JM
AU  - Manero J
AU  - Villa-Blanco I
AU  - Laiz A
AU  - Arteaga MJ
AU  - Cea-Calvo L
AU  - González CM
PY  - 2021
JO  - Medicine
DO  - 10.1097/md.0000000000025223
UR  - https://doi.org/10.1097/md.0000000000025223
ER  - 

APA

JJ, A., X, J., JM, R., J, M., I, V., A, L., MJ, A., L, C., & CM, G. (2021). Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.. Medicine. https://doi.org/10.1097/md.0000000000025223

Source records